Edelweiss Pharma Analytic Acta (ISSN: 2689-9477)
Editor
Robert P Bianchi
President and Chief of Scientific and Technical Affairs
Prescription Drug Research Center
Chicago, USA
Biography
Mr. Bianchi is currently the President and Chief
of Scientific and Technical Affairs at the Prescription Drug Research Center,
Bradenton, FL. He retired as a laboratory director for the Drug Enforcement
Administration after 34 years of federal service, where he held increasingly
responsible positions as an analytical chemist for the FDA and DEA to the chief
of DEA's Laboratory Operations Section. Mr. Bianchi was also director of the
DEA Special Testing and Research Laboratory where extractability experiments
were conducted more than twenty years ago. Since 2005 he has been working with
the pharmaceutical industry and FDA on developing in vitro protocols to
evaluate abuse deterrent formulations and has been actively involved is sharing
his experience with the regulatory, treatment, pharmaceutical abuse and law
enforcement community. For the last decade, he has participated dozens of
category 1 studies on abuse-deterrent opioid formulations, appeared as a
panelist and presenter at abuse deterrent formulation & prescription drug
abuse professional meetings. Mr. Bianchi has provided drug related
consultations to more than thirty organizations/companies concerned about OTC
& prescription drug abuse and has made numerous presentations to the
regulatory, treatment, pharmaceutical, abuse and law enforcement communities.
Mr. Bianchi is also a Special Government Employee for participation in the FDA
Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and
Risk Management Advisory Committee meetings.
Research Interest
Abuse deterrent delivery systems for opioid formulations.
